Smith & Nephew plc income statement SNNUF
In fiscal 2025, which ended Dec 31, 2025, Smith & Nephew plc reported revenue of $6.2 billion, up 6.1% from the year before. Net income was $625.0 million, a profit margin of 10.1%. Operating income came to $794.0 million, an operating margin of 12.9%. Diluted earnings per share were $0.72. Across the 9 fiscal years shown, revenue grew from $4.8 billion in fiscal 2017 to $6.2 billion in fiscal 2025, about 3.3% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6,164
+6.1%
|
5,810
+4.7%
|
5,549
+6.4%
|
5,215
+0.1%
|
5,212
+14.3%
|
4,560
-11.2%
|
5,138
+4.8%
|
4,904
+2.9%
|
4,765
|
| Cost of revenue |
1,972
+11.8%
|
1,764
+2.0%
|
1,730
+12.3%
|
1,540
-0.2%
|
1,543
+10.5%
|
1,396
+4.3%
|
1,338
+3.1%
|
1,298
+4.0%
|
1,248
|
| Gross profit |
4,192
+3.6%
|
4,046
+5.9%
|
3,819
+3.9%
|
3,675
+0.2%
|
3,669
+16.0%
|
3,164
-16.7%
|
3,800
+5.4%
|
3,606
+2.5%
|
3,517
|
| Research and development |
296
+2.4%
|
289
-14.7%
|
339
-1.7%
|
345
-3.1%
|
356
+16.0%
|
307
+5.1%
|
292
+18.7%
|
246
+10.3%
|
223
|
| Selling, general and administrative |
3,102
+0.1%
|
3,100
+1.5%
|
3,055
+6.1%
|
2,880
+5.9%
|
2,720
+6.2%
|
2,562
-4.9%
|
2,693
+7.8%
|
2,497
+5.8%
|
2,360
|
| Operating expenses |
3,398
+0.3%
|
3,389
-0.1%
|
3,394
+5.2%
|
3,225
+4.8%
|
3,076
+7.2%
|
2,869
-3.9%
|
2,985
+8.8%
|
2,743
+6.2%
|
2,583
|
| Operating income |
794
+20.9%
|
657
+54.6%
|
425
-5.6%
|
450
-24.1%
|
593
+101.0%
|
295
-63.8%
|
815
-5.6%
|
863
-7.6%
|
934
|
| Pretax income |
779
+56.4%
|
498
+71.7%
|
290
+23.4%
|
235
-59.9%
|
586
+138.2%
|
246
-66.9%
|
743
-4.9%
|
781
-11.1%
|
879
|
| Income tax |
154
+79.1%
|
86
+218.5%
|
27
+125.0%
|
12
-80.6%
|
62
+130.7%
|
-202
-241.3%
|
143
+21.2%
|
118
+5.4%
|
112
|
| Net income |
625
+51.7%
|
412
+56.7%
|
263
+17.9%
|
223
-57.4%
|
524
+17.0%
|
448
-25.3%
|
600
-9.5%
|
663
-13.6%
|
767
|
| Basic EPS |
0.72
+52.8%
|
0.47
+56.3%
|
0.30
+18.4%
|
0.26
-57.4%
|
0.60
+16.6%
|
0.51
-25.2%
|
0.69
-99.1%
|
76.00
+8556.0%
|
0.88
|
| Diluted EPS |
0.72
+52.3%
|
0.47
+56.1%
|
0.30
+18.0%
|
0.26
-57.3%
|
0.60
+16.6%
|
0.51
-14.2%
|
0.60
-99.2%
|
75.70
+8531.7%
|
0.88
|
| Weighted average shares, basic |
867
-0.7%
|
873
+0.2%
|
871
-0.1%
|
872
-0.6%
|
877
+0.2%
|
875
+0.1%
|
874
+0.1%
|
873
-0.1%
|
874
|
| Weighted average shares, diluted |
873
-0.3%
|
876
+0.3%
|
873
+0.0%
|
873
-0.6%
|
878
+0.1%
|
877
+0.0%
|
877
+0.1%
|
876
+0.1%
|
875
|
| Other measures | |||||||||
| Depreciation and amortization |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
427
-1.8%
|
435
|
| EBITDA |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1,290
-5.8%
|
1,369
|
| Interest coverage |
5.67x
|
4.53x
|
3.22x
|
5.62x
|
7.41x
|
4.76x
|
12.54x
|
14.63x
|
16.39x
|
| Margins | |||||||||
| Gross margin |
68.01%
|
69.64%
|
68.82%
|
70.47%
|
70.40%
|
69.39%
|
73.96%
|
73.53%
|
73.81%
|
| Operating margin |
12.88%
|
11.31%
|
7.66%
|
8.63%
|
11.38%
|
6.47%
|
15.86%
|
17.60%
|
19.60%
|
| Pretax margin |
12.64%
|
8.57%
|
5.23%
|
4.51%
|
11.24%
|
5.39%
|
14.46%
|
15.93%
|
18.45%
|
| Profit margin |
10.14%
|
7.09%
|
4.74%
|
4.28%
|
10.05%
|
9.82%
|
11.68%
|
13.52%
|
16.10%
|
| EBITDA margin |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
26.31%
|
28.73%
|
| Effective tax rate |
19.77%
|
17.27%
|
9.31%
|
5.11%
|
10.58%
|
-82.11%
|
19.25%
|
15.11%
|
12.74%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- SNN (NYSE), SNNUF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Watford, Hertfordshire
- SEC filer status
- Large accelerated filer
- SEC CIK
- 845982
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.